Acute Liver Injury
9
1
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
TReatment for ImmUne Mediated PathopHysiology
Biomarkers in Liver Failure
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
Acute Liver Injury in Patients With Pneumonia
A Multi-Center Trial to Study Acute Liver Failure in Adults
Acute Liver Injury in Patients on Dapagliflozin
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
Liver Function After Intravenous Methylprednisolone Administration
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury